Latest S-1 registration statements

Self-managed healthcare REIT National Healthcare Properties files for a public offering to accelerate its strategic pivot toward senior housing assets.

Legence Corp. filed a registration statement for the secondary offering of 11,000,000 shares of Class A common stock by existing stockholders.

Encore Medical, Inc. has filed an S-1/A amendment to its registration statement, primarily to include Exhibit 4.3, the Form of Investor's Warrant, and an updated Filing Fee Table.

Auddia Inc. has filed an S-1 registration statement detailing an offering of common stock and warrants, with pre-funded warrants available for certain investors.

American Rebel Holdings, Inc. has filed an S-1 registration statement to allow selling stockholders to resell up to 1,196,670 shares of common stock.

Grayscale Bittensor Trust (TAO) has filed an S-1/A amendment with the SEC, detailing its intention to list shares on NYSE Arca under the symbol GTAO, aiming to provide investors with cost-effective exposure to TAO.

Invech Holdings, Inc. has filed a registration statement to register 30,000,000 common shares for resale by GHS Investments LLC under a $10 million equity financing agreement.

Ludwig Enterprises, an early-stage genomics company, is seeking to raise approximately $13.55 million through a firm commitment public offering of common units to fund clinical studies and commercialize its mRNA-based breast cancer test.

Albert Origin Acquisition Corporation, a Cayman Islands blank check company, filed an S-1/A for a $60 million initial public offering of units to pursue a business combination outside of the PRC.

QuasarEdge Acquisition Corporation, a blank check company, filed an amended S-1 registration statement detailing its $100 million IPO, unit structure, and significant risks related to management conflicts and potential China-based acquisitions.

Innovative Digital Investors Acquisition Corp. files S-1/A for a $200M IPO to acquire a financial services business in North America.

Dror Ortho-Design, a pre-revenue medical device company, is pursuing a public offering of up to 3.6 million shares and prefunded warrants to raise $13 million, alongside a 1-for-550 reverse stock split, while facing significant financial challenges and a going concern doubt.

Lakewood-Amedex Biotherapeutics Inc. is pursuing a direct listing on the Nasdaq Capital Market and a $7.5 million Series C Preferred Stock financing to advance its antimicrobial pipeline, despite ongoing significant losses and a going concern warning.

Infleqtion, Inc. has completed its business combination and PIPE financing, raising $551.4 million to accelerate its quantum computing, sensing, and software platforms, despite reporting a net loss of $31.8 million in 2025.

LeonaBio amends its S-1 filing to register 5.5 million common shares for resale by Sermonix Pharmaceuticals, Inc., generating minimal proceeds for LeonaBio from warrant exercise.

LeonaBio, a clinical-stage biopharmaceutical company, filed an S-1/A to register 58.5 million shares for resale by existing stockholders, with potential proceeds of $146 million from warrant exercises for company operations.

Bitcoin Depot Inc. reports a 7.2% revenue increase in 2025, but anticipates a significant revenue decline in 2026 for its core business due to stringent fraud mitigation efforts and regulatory pressures, while diversifying into social betting with the Kutt acquisition.

Spectre Acquisition Corp, a Cayman Islands blank check company, filed an S-1/A for an initial public offering of 6 million units at $10.00 each, aiming to raise $60 million for a business combination outside the PRC.

VivoSim Labs, Inc. files an S-1/A for a best efforts public offering of up to $4 million in common stock and warrants, aiming to fund operations through 2027 despite significant accumulated losses and auditor's going concern warning.

VivoSim Labs, a biotech services firm, is conducting a best efforts public offering of up to $4 million in common stock and warrants to fund operations, despite an auditor's 'going concern' warning and significant accumulated losses.

FibroBiologics, Inc. announces a public offering of common stock and warrants to raise capital and address ongoing Nasdaq listing compliance issues, including a recent 1-for-20 reverse stock split.

Selling shareholders of WaterBridge Infrastructure LLC are offering up to 83,250,000 Class A shares, with the company receiving no proceeds from the resale.

Ideal Power Inc. filed an S-1 registration statement for the potential resale of 631,332 shares of common stock by a selling securityholder, issuable upon exercise of pre-funded warrants.

First Choice Healthcare Solutions, Inc. is undergoing a major strategic shift from orthopedics to a national chain of primary care and wellness clinics, aiming to raise up to $19 million in a public offering.

CIMG Inc. is seeking to raise up to $650 million through a direct offering of units and warrants, payable in cash or Bitcoin, as it navigates a recent delisting from Nasdaq and shifts its business focus to health and AI products in Asia.

VenHub Global, an autonomous retail technology company, filed an S-1 registration statement for the resale of up to 16.485 million common shares by existing stockholders, reporting significant net losses and a going concern opinion.

Artelo Biosciences files an S-1 registration statement for the resale of up to 4.27 million common shares by Square Gate Capital, potentially accessing up to $50 million in future equity financing.

Forgent Power Solutions, Inc. is undertaking a follow-on public offering of Class A Common Stock to fund the redemption of Opco LLC Interests from existing equity owners.

Artelo Biosciences, a clinical-stage biopharmaceutical company, is conducting a best-efforts public offering to raise up to $10.9 million while addressing Nasdaq listing compliance issues and reporting positive interim clinical trial data.

Netcapital Inc. is registering shares for resale and seeking up to $9.21 million from warrant exercises while grappling with a Nasdaq minimum bid price deficiency and an ongoing SEC enforcement investigation.